Olio Labs

Tool Information

Primary Task	Medical research
Category	specialized-technologies
Country	United States

Olio Labs is a biotechnology company based in San Francisco that utilizes artificial intelligence to develop combination therapeutics for complex diseases. Founded by systems neuroscientists David and Tom, the company aims to overcome the limitations of traditional single-target drug discovery by modeling interactions among thousands of proteins in the human body.

Their AI-driven computational platform allows for rapid testing of therapeutic combinations, enabling the evaluation of trillions of potential drug interactions. This innovative approach helps identify effective combinations with fewer side effects. Olio's pipeline includes lead therapeutic combinations that demonstrate improved efficacy and safety compared to existing market-leading drugs. The company integrates computational biology, machine learning, and biological insights to automate drug discovery processes, with plans to expand into various disease areas.

Olio Labs is committed to transforming drug discovery by focusing on a patient-first approach, prioritizing precision and reduced side effects through combinatorial therapeutics.